ArticleExperimental and therapeutic medicine2016

Sitagliptin attenuates inflammatory responses in lipopolysaccharide-stimulated cardiomyocytes via nuclear factor-κB pathway inhibition.

Chien-Hung Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.